[1] |
PENG Youbin, LIN Hao, LI Ming, HUANG Haihua.
Expression of TPX2 and its clinicalsignificance in non-muscle-invasive bladder cancer
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 30-34.
|
[2] |
JIAO Wenpeng, HOU Lin, CUI Meijuan, JIAO Wenjing, MA Ming, ZHANG Jinyan.
Expression of miR-93-5p and miR-106b-5p in alcohol-related liver cancer and its clinical significance
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 430-434.
|
[3] |
GAO Xiaobin, WU Xueliang, WANG Shengjie, SUN Guangyuan, WANG Wenjing, LIANG Feng, ZHAO Yifeng, LIU Zhenxian, ZHANG Yingchun.
Expression of TRIM59 and its correlations with clinicopathological features in colorectal cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 446-450.
|
[4] |
JIAO Wenjing, ZHANG Jinyan, MA Ming, GUO Xiujuan, FENG Junhua, SHAO Junguo, JIAO Wenpeng.
Expression and clinical significance of MTDH and FoxM1 in hepatocellular carcinomas
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(5): 349-353,359.
|
[5] |
ZHANG Shimin, ZHAO Ruijun.
Expression of protein tyrosine phosphatase receptor J in breast cancer tissues and its relationship with clinical prognosis
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 276-279,285.
|
[6] |
LIU Xiaoxia, LI Weixia, LI Zhijia, SU Zhenjun, DUAN Xiaohui, HAN Weiwen, WANG Yunxiao, HE Xiaolei, Lu Linlin, JIA Jinhai.
Correlations between glutathione peroxidase in serum and clinicopathological outcomes of advanced non-small cell lung cancer
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 286-290,295.
|
[7] |
ZHANG Yuling, WU Jundong, PANG Dongyue, CHEN Chunfa.
Changes of Ki67 expression before and after neoadjuvant chemotherapy as a predictor for therapeutic response and rognosis in breast cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 230-235,245.
|
[8] |
JIAO Wenjing, GUO Xiujuan, MA Ming, SHAO Junguo, ZHANG Jinyan.
Comparative efficacies between concurrent chemo-radiotherapy and radiotherapy alone in elderly patients with locally advanced esophageal cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 124-128.
|
[9] |
CHEN Wanxian, WANG Simeng, CHEN Zhangyu, WANG Panji, ZHENG Chunwen, LI Enmin, XU Liyan.
CASIN, a CDC42 inhibitor, inhibited viability and migration of esophageal carcinoma cells in vitro
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 136-142.
|
[10] |
SHI Hailin, HE Tianji, LIU Feng, CAI Menghui, GE Bo.
Prognostic value of TCGA-database mutation burden in muscle-invasive bladder cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 430-437,443.
|
[11] |
DING Yawen, JIAO Wenjing, WANG Pengyu, LU Gang, MA Ming.
Immunophenotype characteristics of plasma cells and clinical significance in multiple myeloma patients
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 464-468,489.
|
[12] |
SHAO Junguo, JIAO Wenjing, WANG Xuexiao, ZHANG Jinyan, MA Ming.
Clinical significance of mi-429 and Bmi-1 mRNA expressions in lung carcinoma tissues
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(5): 369-373.
|
[13] |
Lü Yanping, WU Chuancheng, YANG Shuangfeng, HE Chenzhou, HAN Renjie, YAN Wei, LIU Baoying.
Relationship between differentially expressed miRNA-SNPs and prognosis of gastric cancer
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(5): 380-386.
|
[14] |
GUO Xiujuan, DU Yanyan, YAN Xi, ZHAO Xuetao, HAN Lina, WU Yipeng, WANG Xuexiao, MA Ming.
Expression and clinical significance of CREB in esophageal squamous cell carcinoma tissues
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(5): 387-390,394.
|
[15] |
YANG Li, ZHANG Mengxian, ZHANG Wei, XIONG Yingyou, CHEN Shiyong, FANG Chengxiang.
Data mining to investigate expression and significance of aurora kinase A in esophageal carcinoma
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 221-228.
|